Swan Sit Insider Profile

4 Followers
Swan Sit, Director at NovaBay Pharma, holds 15.50K shares in Edgewell Personal Care (Ticker: EPC), holds 1.72K shares in NovaBay Pharma (Ticker: NBY).
tipranks
Swan Sit

Swan Sit
NovaBay Pharma (NBY)
Director

Not Ranked
Swan Sit has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$562K
99.79%
0.21%
A breakdown of Swan Sit's holdings

Insider Roles

Edgewell Personal Care
(EPC)
Director
NovaBay Pharma
(NBY)
Director
Roles that Swan Sit holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Swan Sit

Swan Sit's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NovaBay Pharma
May 15, 2023
Director
Uninformative Buy
857.14
$1.19K
Edgewell Personal Care
Jan 31, 2024
Director
Uninformative Buy
122.93K
$560.44K
List of latest transactions for each holding click on a transaction to see Swan Sit's performance on stock

Swan Sit insider profile FAQ

What is the percentage of profitable transactions made by Swan Sit?
The percentage of profitable transactions made by Swan Sit is ―.
    What is the average return per transaction made by Swan Sit?
    The average return per transaction made by Swan Sit is ―.
      What stocks does Swan Sit hold?
      Swan Sit holds: NBY, EPC stocks.
        What was Swan Sit’s latest transaction?
        Swan Sit latest transaction was an Uninformative Buy of $122.93K.
          What was Swan Sit's most profitable transaction?
          Swan Sit’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Swan Sit's role in NovaBay Pharma?
            Swan Sit's role in NovaBay Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.